Skip to main content
. 2019 Jul 5;11(7):318. doi: 10.3390/pharmaceutics11070318

Figure 2.

Figure 2

Mean arterial plasma concentration-time profiles of tofacitinib in Sprague-Dawley rats after (A) 1-min intravenous infusion of 5 (n = 9), 10 (n = 8), 20 (n = 7), and 50 (n = 7) mg/kg tofacitinib and (B) oral administration of 10 (n = 7), 20 (n = 8), 50 (n = 9), and 100 (n = 7) mg/kg tofacitinib. Bars represent standard deviations (SD).